These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27636237)

  • 1. A HAART-Breaking Review of Alternative Antiretroviral Administration: Practical Considerations with Crushing and Enteral Tube Scenarios.
    Huesgen E; DeSear KE; Egelund EF; Smith R; Max B; Janelle J
    Pharmacotherapy; 2016 Nov; 36(11):1145-1165. PubMed ID: 27636237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of oral antiretroviral administration in patients with swallowing disorders or with an enteral feeding tube.
    San C; Lê MP; Matheron S; Mourvillier B; Caseris M; Timsit JF; Wolff M; Yazdanpanah Y; Descamps D; Peytavin G
    Med Mal Infect; 2020 Oct; 50(7):537-544. PubMed ID: 31722864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of antiretroviral medication via enteral tubes.
    Prohaska ES; King AR
    Am J Health Syst Pharm; 2012 Dec; 69(24):2140-6. PubMed ID: 23230036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When patients cannot take pills: antiretroviral drug formulations for managing adult HIV infection.
    Nyberg CR; Patterson BY; Williams MM
    Top Antivir Med; 2011; 19(3):126-31. PubMed ID: 21946391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute Care Management of the HIV-Infected Patient: A Report from the HIV Practice and Research Network of the American College of Clinical Pharmacy.
    Durham SH; Badowski ME; Liedtke MD; Rathbun RC; Pecora Fulco P
    Pharmacotherapy; 2017 May; 37(5):611-629. PubMed ID: 28273373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative antiretroviral therapy formulations for patients unable to swallow solid oral dosage forms.
    Duggan JM; Akpanudo B; Shukla V; Gutterson G; Eitniear L; Sahloff EG
    Am J Health Syst Pharm; 2015 Sep; 72(18):1555-65. PubMed ID: 26346211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dual role of pharmacogenetics in HIV treatment: mutations and polymorphisms regulating antiretroviral drug resistance and disposition.
    Michaud V; Bar-Magen T; Turgeon J; Flockhart D; Desta Z; Wainberg MA
    Pharmacol Rev; 2012 Jul; 64(3):803-33. PubMed ID: 22759796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lopinavir/ritonavir-based antiretroviral therapy in human immunodeficiency virus type 1-infected naive children: rare protease inhibitor resistance mutations but high lamivudine/emtricitabine resistance at the time of virologic failure.
    Frange P; Briand N; Avettand-fenoel V; Veber F; Moshous D; Mahlaoui N; Rouzioux C; Blanche S; Chaix ML
    Pediatr Infect Dis J; 2011 Aug; 30(8):684-8. PubMed ID: 21427626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication administration through enteral feeding tubes.
    Williams NT
    Am J Health Syst Pharm; 2008 Dec; 65(24):2347-57. PubMed ID: 19052281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The concept of structured treatment interruptions in the management of patients with human immunodeficiency virus (HIV) disease: where are we currently?
    Idemyor V
    HIV Clin Trials; 2003; 4(2):79-83. PubMed ID: 12671774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for overcoming resistance in HIV-1 infected patients receiving HAART.
    Clotet B
    AIDS Rev; 2004; 6(3):123-30. PubMed ID: 15595429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic consideration for the use of antiretroviral agents in the elderly.
    Rhee MS; Greenblatt DJ
    J Clin Pharmacol; 2008 Oct; 48(10):1212-25. PubMed ID: 18812611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Review of enteral drugs administration for viral diseases: HIV, HBV and HCV].
    Arenas Villafranca JJ; Nieto Guindo M; Romero Domínguez R; Tortajada Goitia B; Faus Felipe V
    Farm Hosp; 2013; 37(5):412-8. PubMed ID: 24128105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enteral Administration of Twice-Daily Dolutegravir and Rilpivirine as a Part of a Triple-Therapy Regimen in a Critically Ill Patient with HIV.
    Turley SL; Fulco PP
    J Int Assoc Provid AIDS Care; 2017; 16(2):117-119. PubMed ID: 28198203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-daily highly active antiretroviral therapy for HIV-infected children: safety and efficacy of an efavirenz-containing regimen.
    Scherpbier HJ; Bekker V; Pajkrt D; Jurriaans S; Lange JM; Kuijpers TW
    Pediatrics; 2007 Mar; 119(3):e705-15. PubMed ID: 17308244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncologic complications of human immunodeficiency virus infection: changing epidemiology, treatments, and special considerations in the era of highly active antiretroviral therapy.
    Klibanov OM; Clark-Vetri R
    Pharmacotherapy; 2007 Jan; 27(1):122-36. PubMed ID: 17192166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of HIV infection after triple class failure.
    Cossarini F; Spagnuolo V; Gianotti N; Carbone A; Lazzarin A; Castagna A
    New Microbiol; 2013 Jan; 36(1):23-39. PubMed ID: 23435813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation and control of the human immunodeficiency virus.
    Stengel RF
    Math Biosci; 2008 Jun; 213(2):93-102. PubMed ID: 18439629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.